Cancer Incidence and Mortality for All Sites of Cancer, Westchester County, 2010-2014

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males Females Males Females
Average Annual Cases Rate per 100,000 Males 95% CI (+/-) Average Annual Cases Rate per 100,000 Females 95% CI (+/-) Average Annual Deaths Rate per 100,000 Males 95% CI (+/-) Average Annual Deaths Rate per 100,000 Females 95% CI (+/-)
All Invasive Malignant Tumors 2738.6 539.0 9.2 2869.6 453.9 7.6 808.4 163.3 5.1 865.8 124.0 3.8
Oral cavity and pharynx
All Oral cavity and pharynx 80.0 15.2 1.5 36.0 5.5 0.8 13.2 2.6 0.6 6.6 0.9 0.3
Lip 1.2 0.2 0.2 0.6 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0
Tongue 25.6 4.7 0.8 9.4 1.5 0.4 3.4 0.7 0.3 1.8 0.3 0.2
Salivary gland 9.2 1.9 0.6 8.2 1.2 0.4 1.6 0.3 0.2 1.0 0.1 0.1
Floor of mouth 4.0 0.8 0.3 1.4 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.0
Gum & other mouth 9.0 1.8 0.5 9.8 1.5 0.4 1.2 0.2 0.2 1.4 0.2 0.1
Nasopharynx 6.4 1.3 0.4 1.4 0.3 0.2 1.0 0.2 0.2 0.8 0.1 0.1
Tonsil 13.4 2.5 0.6 3.2 0.5 0.2 1.4 0.3 0.2 0.2 0.0 0.1
Oropharynx 3.8 0.7 0.3 0.8 0.1 0.1 0.8 0.2 0.2 0.2 0.0 0.1
Hypopharynx 5.4 1.0 0.4 1.2 0.2 0.1 0.8 0.2 0.2 0.2 0.0 0.1
Other buccal cavity and pharynx 2.0 0.4 0.2 0.0 0.0 0.0 2.8 0.5 0.3 0.8 0.1 0.1
Digestive system
All Digestive system 489.0 96.3 3.9 456.4 68.0 2.9 243.6 48.3 2.8 211.4 29.8 1.9
Esophagus 29.2 5.6 0.9 15.0 2.1 0.5 26.2 5.1 0.9 13.4 1.9 0.5
Stomach 54.2 10.9 1.3 42.8 6.3 0.9 25.6 5.1 0.9 18.4 2.6 0.6
Small intestine 13.6 2.7 0.6 11.6 1.9 0.5 3.6 0.8 0.4 2.0 0.3 0.2
Colorectal 225.0 44.9 2.7 222.8 33.4 2.0 78.2 15.4 1.6 70.8 10.0 1.1
Colon excluding rectum 156.6 31.6 2.2 167.4 24.7 1.7 64.0 12.6 1.4 58.6 8.3 1.0
Cecum 32.4 6.5 1.0 37.2 5.4 0.8            
Appendix 6.0 1.2 0.4 7.0 1.2 0.4            
Ascending colon 30.4 6.3 1.0 34.2 5.1 0.8            
Hepatic flexure 6.8 1.5 0.5 7.8 1.0 0.3            
Transverse colon 14.6 3.0 0.7 19.2 2.7 0.6            
Splenic flexure 5.6 1.1 0.4 3.8 0.5 0.2            
Descending colon 11.0 2.2 0.6 10.8 1.6 0.4            
Sigmoid colon 40.8 8.0 1.1 36.4 5.6 0.8            
Large intestine, NOS 9.0 1.8 0.5 11.0 1.6 0.4            
Rectum & rectosigmoid 68.4 13.3 1.4 55.4 8.6 1.0 14.2 2.8 0.7 12.2 1.7 0.5
Rectosigmoid junction 18.0 3.6 0.8 14.8 2.2 0.5            
Rectum 50.4 9.7 1.2 40.6 6.4 0.9            
Anus, anal canal & anorectum 6.2 1.2 0.4 15.6 2.4 0.5 1.2 0.2 0.2 2.2 0.3 0.2
Liver and intrahepatic bile duct 58.0 10.6 1.2 26.6 4.1 0.7 38.2 7.4 1.1 24.4 3.5 0.6
Liver 52.8 9.6 1.2 19.2 3.0 0.6 28.6 5.4 0.9 15.0 2.1 0.5
Intrahepatic bile duct 5.2 1.0 0.4 7.4 1.1 0.4 9.6 2.0 0.6 9.4 1.5 0.4
Gallbladder 6.6 1.3 0.5 11.0 1.6 0.4 2.6 0.5 0.3 5.6 0.8 0.3
Other biliary 11.4 2.3 0.6 11.2 1.7 0.4 2.6 0.5 0.3 2.4 0.3 0.2
Pancreas 78.6 15.6 1.6 88.6 12.9 1.2 61.6 12.4 1.4 69.8 9.7 1.0
Retroperitoneum 3.4 0.7 0.3 2.8 0.4 0.2 0.6 0.1 0.1 0.2 0.0 0.1
Peritoneum, omentum & mesentery 0.0 0.0 0.0 6.4 0.9 0.3 0.4 0.1 0.1 1.8 0.2 0.2
Other digestive organs 2.8 0.6 0.3 2.0 0.3 0.2 2.8 0.6 0.3 0.4 0.1 0.1
Respiratory system
All Respiratory system 313.4 62.8 3.2 340.4 50.8 2.5 195.8 39.7 2.5 206.0 29.5 1.8
Nasal cavity, middle ear & sinuses 5.0 1.0 0.4 3.0 0.5 0.3 0.4 0.1 0.1 0.0 0.0 0.0
Larynx 26.2 5.1 0.9 6.4 1.0 0.3 6.0 1.2 0.4 1.4 0.2 0.2
Lung and bronchus 279.8 56.1 3.0 330.0 49.2 2.4 188.8 38.3 2.5 204.2 29.3 1.8
Pleura 0.4 0.1 0.1 0.4 0.1 0.1 0.4 0.1 0.1 0.4 0.0 0.1
Trachea, mediastinum, other respiratory 2.0 0.5 0.3 0.6 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0
Soft tissue, bone, and skin
Bones & joints 7.0 1.5 0.5 5.2 1.0 0.4 2.0 0.4 0.3 1.2 0.2 0.2
Soft tissue (including heart) 20.2 4.2 0.8 16.2 2.8 0.6 7.4 1.5 0.5 7.0 1.2 0.4
Skin~ 151.6 30.1 2.2 102.6 16.6 1.5 23.6 4.9 0.9 15.6 2.1 0.5
Melanoma of the skin 139.4 27.6 2.1 94.2 15.2 1.4 18.4 3.8 0.8 13.6 1.9 0.5
Breast
Breast 8.6 1.7 0.5 866.6 140.8 4.3 1.4 0.3 0.2 127.4 18.7 1.5
Female genital system
All Female genital system       341.6 54.1 2.6       106.8 15.7 1.4
Cervix uteri       35.2 6.4 1.0       10.0 1.6 0.5
Corpus uterus and NOS       195.8 30.3 1.9       39.6 5.8 0.8
Ovary       79.2 12.7 1.3       51.6 7.5 0.9
Vagina       4.8 0.7 0.3       0.6 0.1 0.1
Vulva       14.6 2.1 0.5       4.0 0.6 0.3
Other female genital organs       12.0 1.9 0.5       1.0 0.1 0.1
Male genital system
All Male genital system 780.8 148.6 4.7       90.6 18.7 1.7      
Prostate 749.6 141.7 4.6       89.4 18.5 1.7      
Testis 28.0 6.4 1.1       0.6 0.1 0.2      
Penis 1.6 0.3 0.2       0.4 0.1 0.1      
Other male genital organs 1.6 0.3 0.2       0.2 0.0 0.1      
Urinary system
All Urinary system 321.2 64.0 3.2 132.2 19.7 1.5 56.0 11.4 1.4 23.8 3.1 0.6
Urinary bladder (including in situ) 198.8 40.2 2.5 70.2 10.1 1.1 32.6 6.7 1.0 13.2 1.7 0.4
Kidney and renal pelvis 116.4 22.6 1.9 57.0 8.8 1.0 21.8 4.4 0.8 9.2 1.2 0.4
Ureter 4.2 0.8 0.4 4.0 0.6 0.3 0.8 0.2 0.2 1.0 0.2 0.1
Other urinary organs 1.8 0.3 0.2 1.0 0.1 0.1 0.8 0.2 0.2 0.4 0.0 0.1
Eye & orbit
Eye & orbit 5.6 1.1 0.4 5.2 0.9 0.4 0.2 0.1 0.1 0.2 0.0 0.1
Brain and central nervous system
All Brain / other nervous system (all behaviors) 87.0 17.4 1.7 117.8 19.3 1.6 27.2 5.4 0.9 26.4 3.8 0.7
Malignant brain / other nervous system 38.8 7.9 1.1 33.4 5.5 0.9 22.6 4.5 0.8 20.0 3.0 0.6
Malignant brain 35.6 7.2 1.1 31.8 5.2 0.8            
Malignant other nervous system 3.2 0.6 0.3 1.6 0.3 0.2            
Benign brain / other nervous system* 48.2 9.5 1.2 84.4 13.8 1.4 4.6 1.0 0.4 6.4 0.8 0.3
Benign brain 7.2 1.5 0.5 7.6 1.4 0.5            
Benign other nervous system 41.0 8.0 1.1 76.8 12.5 1.3            
Endocrine system
All Endocrine system 68.0 13.7 1.5 164.4 31.0 2.2 5.0 1.1 0.4 4.8 0.8 0.3
Thyroid 60.6 12.1 1.4 159.2 30.1 2.1 3.4 0.7 0.3 2.6 0.3 0.2
Other endocrine (including thymus) 7.4 1.6 0.5 5.2 0.9 0.4 1.6 0.4 0.3 2.2 0.4 0.3
Lymphomas
All Lymphomas 163.2 33.0 2.3 140.0 22.5 1.7 33.0 6.7 1.0 36.8 5.1 0.8
Hodgkin lymphoma 20.4 4.5 0.9 14.6 2.9 0.7 1.6 0.3 0.2 1.6 0.2 0.2
Non-Hodgkin lymphomas 142.8 28.6 2.1 125.4 19.5 1.6 31.4 6.4 1.0 35.2 4.8 0.7
Myeloma
All Myeloma 57.4 11.4 1.3 40.4 6.0 0.8 16.6 3.3 0.7 18.4 2.5 0.5
Leukemias
All Leukemias 118.6 24.1 2.0 90.4 14.0 1.3 46.0 9.7 1.3 31.0 4.4 0.7
Lymphocytic leukemias 70.4 14.3 1.5 49.0 7.5 1.0 12.8 2.7 0.7 7.0 1.1 0.4
Acute lymphocytic leukemia 9.8 2.2 0.6 9.0 1.8 0.5 2.6 0.5 0.3 1.8 0.3 0.2
Chronic lymphocytic leukemia 53.4 10.7 1.3 38.8 5.6 0.8 9.2 1.9 0.6 4.8 0.7 0.3
Other lymphocytic leukemias 7.2 1.5 0.5 1.2 0.1 0.1 1.0 0.2 0.2 0.4 0.1 0.1
Myeloid and monocytic leukemias 43.0 8.8 1.2 37.6 6.0 0.9 21.4 4.5 0.9 15.8 2.3 0.5
Acute myeloid leukemia 26.6 5.5 1.0 26.0 4.0 0.7 18.8 3.9 0.8 14.2 2.1 0.5
Acute monocytic leukemia 1.2 0.2 0.2 1.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0
Chronic myeloid leukemia 14.0 2.7 0.7 9.4 1.6 0.5 1.4 0.3 0.2 1.4 0.2 0.2
Other myeloid/monocytic leukemias 1.2 0.2 0.2 0.8 0.1 0.1 1.2 0.2 0.2 0.2 0.0 0.0
Other leukemias 5.2 1.0 0.4 3.8 0.6 0.3 11.8 2.5 0.6 8.2 1.1 0.3
Other acute leukemias 0.8 0.2 0.2 1.0 0.1 0.1 4.0 0.8 0.4 3.2 0.4 0.2
Aleukemic, subacute, leukemia NOS 4.4 0.8 0.4 2.8 0.4 0.2 7.8 1.7 0.5 5.0 0.6 0.3
Mesothelioma
Mesothelioma 6.6 1.4 0.5 3.2 0.5 0.3            
Kaposi sarcoma
Kaposi sarcoma 4.0 0.8 0.4 1.0 0.1 0.1            
Myelodysplastic syndromes
Myelodysplastic syndromes 43.2 9.0 1.2 23.8 3.4 0.6            
Chronic myeloproliferative disorders^
Chronic myeloproliferative disorders^ 20.4 4.1 0.8 26.2 4.2 0.7            
Ill defined and unspecified sites
Ill defined and unspecified sites 41.0 8.1 1.1 44.4 6.5 0.9 50.8 10.2 1.3 48.6 6.9 0.9

Key

Symbol Meaning
~ Incidence of skin cancer excludes basal and squamous cell cancers.
* Brain and other nervous system tumors with benign or uncertain behaviors are not included in the total for all invasive malignant tumors.
^ Tumors with a histology of 9963 or 9964 are included under Aleukemic, Subacute, Leukemia NOS, instead of Chronic Myeloproliferative Disorder.

Notes

  • Incidence data are provisional, November 2016.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.